Sodium Bicarbonate and N-Acetylcysteine for Nephroprotection in Acute Myocardial Infarction
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
Contrast-induced nephropathy (CIN) represents a potential complication of diagnostic and
therapeutic procedures in interventional cardiology, especially in the acute setting of
primary PCI. The investigators will test the efficacy of sodium bicarbonate (NaHCO3) and
N-acetylcysteine (NAC) on the prevention of acute events and CIN in patients with acute
myocardial infarction.